Patricia Steinert

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 434 citations · Full text

Medicine, Hematology, Oncology +17

Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)

Marcelo C. Pasquini, Frederick L. Locke, Alex F. Herrera et al. · Blood · 2019 · 95 citations

Medicine, Hematology, Oncology +15

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity

Mary Eapen, Ruta Brazauskas, Michael Hemmer et al. · Blood Advances · 2018 · 82 citations · Full text

Medicine, Hematology, Oncology +17

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes

Rachel Phelan, Min Chen, Caitrin Bupp et al. · Transplantation and Cellular Therapy · 2022 · 82 citations · Full text

Medicine, Hematology, Pediatrics +16

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry

Samantha Jaglowski, Zhen‐Huan Hu, Yiyun Zhang et al. · Blood · 2019 · 78 citations

Medicine, Hematology, Oncology +17